Many NHS trusts reject Palantir patient data platform after trials and reviews
Sixteen NHS trusts and health boards in England said they do not use Palantir’s federated data platform after trials or review. Some trusts found the platform offered no clear benefit over existing systems while others reverted to legacy software. The responses affect the seven-year NHS contract worth about £330 million and the government’s decision on a break clause.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.